Innovent Biologics Stock Price on November 1, 2024
| IVBXF Stock | USD 4.86 0.03 0.62% |
If you're considering investing in Innovent Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Innovent Biologics stands at 4.86, as last reported on the 14th of December 2024, with the highest price reaching 4.86 and the lowest price hitting 4.86 during the day. Innovent Biologics holds Efficiency (Sharpe) Ratio of -0.0401, which attests that the entity had a -0.0401% return per unit of risk over the last 3 months. Innovent Biologics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Innovent Biologics' Market Risk Adjusted Performance of (0.97), standard deviation of 3.61, and Risk Adjusted Performance of (0.02) to validate the risk estimate we provide.
Innovent Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Innovent |
Sharpe Ratio = -0.0401
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IVBXF |
Estimated Market Risk
| 3.61 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Innovent Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innovent Biologics by adding Innovent Biologics to a well-diversified portfolio.
Innovent Biologics Valuation on November 1, 2024
It is possible to determine the worth of Innovent Biologics on a given historical date. On November 1, 2024 Innovent was worth 4.57 at the beginning of the trading date compared to the closed value of 4.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Innovent Biologics pink sheet. Still, in general, we apply an absolute valuation method to find Innovent Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Innovent Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Innovent Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 4.57 | 4.57 | 4.57 | 4.57 | 1.00 | |
11/01/2024 | 4.57 | 4.57 | 4.57 | 4.57 | 1.00 |
| 5.11 | 5.11 | 5.11 | 5.11 | 450.00 |
| Backtest Innovent Biologics | | | Innovent Biologics History | | | Innovent Biologics Valuation | Previous | Next |
Innovent Biologics Trading Date Momentum on November 1, 2024
| On November 04 2024 Innovent Biologics was traded for 5.11 at the closing time. The highest daily price throughout the period was 5.11 and the lowest price was 5.11 . The daily volume was 450. The net trading volume on 11/04/2024 added to the next day price rise. The trading delta at closing time to closing price of the next trading day was 11.82% . The trading delta at closing time to current closing price is 5.03% . |
Innovent Biologics Fundamentals Correlations and Trends
By evaluating Innovent Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Innovent Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Innovent financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Innovent Biologics Pink Sheet history
Innovent Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Innovent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Innovent Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Innovent Biologics stock prices may prove useful in developing a viable investing in Innovent Biologics
Innovent Biologics, Inc. operates as a biopharmaceutical company in China. Innovent Biologics, Inc. was incorporated in 2011 and is headquartered in Suzhou, the Peoples Republic of China. Innovent Biologics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5538 people.
Innovent Biologics Pink Sheet Technical Analysis
Innovent Biologics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Innovent Biologics Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Innovent Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Innovent Biologics December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Innovent Biologics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innovent Biologics shares will generate the highest return on investment. By undertsting and applying Innovent Biologics pink sheet market strength indicators, traders can identify Innovent Biologics entry and exit signals to maximize returns
Innovent Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Innovent Biologics' price direction in advance. Along with the technical and fundamental analysis of Innovent Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Innovent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.98) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Innovent Pink Sheet analysis
When running Innovent Biologics' price analysis, check to measure Innovent Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovent Biologics is operating at the current time. Most of Innovent Biologics' value examination focuses on studying past and present price action to predict the probability of Innovent Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovent Biologics' price. Additionally, you may evaluate how the addition of Innovent Biologics to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world |